Product Information
TOBRADEX ST 0.3-0.05% EYE DROP is a brand product labeled by Eyevance Pharmaceuticals, LLC, priced at $46.6196 per ML under NDC 71776003505. Its NADAC has been published 268 times since Jul 7, 2021.
FDA first approved this application on Feb 13, 2009.
Strength
.5; 3 mg/mL; mg/mL
Manufacturer
Eyevance Pharmaceuticals, LLCNDC
71776003505
Classification
Brand
Dosage Form
SUSPENSION/ DROPS
Route
OPHTHALMIC
Effective Date
8/19/2026
Active Ingredients
DEXAMETHASONE; TOBRAMYCINApproval Type
New Drug (NDA)
FDA Application
NDA050818FDA Approved
2/13/2009
On Market Since
5/19/2021
Pharmacological Classes
Price Statistics
The NADAC for TOBRADEX ST 0.3-0.05% EYE DROP has been published 268 times since Jul 7, 2021, and over the history we have for it it has risen 7.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $46.6196 per ML |
|---|---|
| All-time high | $46.7851 (Sep 10, 2025) |
| All-time low | $43.5869 (Jul 7, 2021) |
| 52-week high | $46.7851 |
| 52-week low | $46.6196 |
| Median price | $45.7611 |
| Average price | $45.8757 |
| Largest weekly change | +5.0% (Aug 11, 2021) |
| Weeks tracked | 268 |
| Tracking since | Jul 7, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TOBRADEX ST 0.3-0.05% EYE DROP?
The current National Average Drug Acquisition Cost (NADAC) for TOBRADEX ST 0.3-0.05% EYE DROP, manufactured by Eyevance Pharmaceuticals, LLC, is $46.6196 per ML (NDC 71776003505), effective Aug 19, 2026.
How has the price of TOBRADEX ST 0.3-0.05% EYE DROP changed over time?
Over the history we have for it, the NADAC for TOBRADEX ST 0.3-0.05% EYE DROP has risen 7.0%. It has been tracked across 268 weekly CMS publications since Jul 7, 2021.
What are the highest and lowest recorded NADAC prices for TOBRADEX ST 0.3-0.05% EYE DROP?
Since Jul 7, 2021, the NADAC for TOBRADEX ST 0.3-0.05% EYE DROP has ranged from a low of $43.5869 (Jul 7, 2021) to a high of $46.7851 (Sep 10, 2025), with a median of $45.7611 per ML.
Are there cheaper alternatives to TOBRADEX ST 0.3-0.05% EYE DROP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TOBRADEX ST 0.3-0.05% EYE DROP in a comparable dosage form, but none are currently priced below it.
Who manufactures TOBRADEX ST 0.3-0.05% EYE DROP?
TOBRADEX ST 0.3-0.05% EYE DROP (NDC 71776003505) is labeled by Eyevance Pharmaceuticals, LLC, and CMS classifies it as a brand product.